Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)

NCT: NCT06375967 · SUSPENDED

NCT IDNCT06375967
StatusSUSPENDED
Start Date2024-10-18
Completion2027-10

Brief Summary

The aim of the study is to evaluate technical, clinical and safety outcomes of lumen-apposing metal stent (LAMS) with a coaxial double-pigtail plastic stent (DPS) in EUS-guided choledochoduodenostomies vs cholcystogastrostomy for the management of malignant biliary obstruction in palliative patients.

Frequently Asked Questions

What is EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)?

EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial) is a clinical trial registered under NCT06375967. Current status: SUSPENDED.

What is the status of NCT06375967?

The current status of NCT06375967 (EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)) is: SUSPENDED.

When did EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial) start?

EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial) started on 2024-10-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑